MMED (MiniMed Group, Inc. Common Stock) Stock Analysis

MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of May 21, 2026, MMED trades at $11.63 with a market cap of $3.06B and a P/E ratio of 0.00. MMED moved +6.98% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $20.48. Analyst consensus is strong buy with an average price target of $20.85. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest MMED stock research?

MiniMed Group, Inc. Common Stock (MMED) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MMED moved +6.98% today. Analyst consensus is strong buy.

MMED Key Metrics

Key financial metrics for MMED
MetricValue
Price$11.63
Market Cap$3.06B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$20.48
52-Week Low$10.65
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MMED News

Recent MMED Insider Trades

  • Torbert Hank bought 10 (~$3.8) on Apr 24, 2013.
  • Torbert Hank bought 20 (~$29) on Mar 20, 2012.
  • Kachidza Johnson M bought 50.00K (~$250.00K) on Feb 22, 2010.

MMED Analyst Consensus

13 analysts cover MMED: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.85.

Common questions about MMED

What can I research for MMED on Rallies?
MiniMed Group, Inc. Common Stock (MMED) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MMED moved +6.98% today. Analyst consensus is strong buy.
Does Rallies show live market data for MMED?
Rallies combines live market context with ticker research for MMED, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
MMED

MMED